The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats

Inflammopharmacology

Volumn 15, Issue 6, 2007, Pages 260-265

  Batu, O S ^a   Erol, K ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Cyclooxygenase; Dipyrone; Experimental ulcer; Lipid peroxidase; Myeloperoxidase

Indexed keywords

CELECOXIB; DIETHYLDITHIOCARBAMIC ACID; DIPYRONE; HISTAMINE; LIPID PEROXIDE; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; THIOL DERIVATIVE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH PH; STOMACH ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DIPYRONE; DITIOCARB; GASTRIC ACIDITY DETERMINATION; GASTRIC MUCOSA; HISTAMINE; LIPID PEROXIDES; MALE; MALONDIALDEHYDE; MUCUS; PEROXIDASE; PYRAZOLES; RATS; STOMACH ULCER; STRESS, PSYCHOLOGICAL; SULFHYDRYL COMPOUNDS; SULFONAMIDES;

EID: 38849164765     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-1605-1     Document Type: Article

References (45)

1. Aguwa, C. N. (1984). Effects of exogenous administration of female sex hormones on gastric secretion and ulcer formation in the rat. Eur. J. Pharmacol. 3, 104(1-2): 79-84.
2. Al-Bekairi, A. M., Al-Rajhi, A. M., Tariq, M. (1993). Effect of (±)-propranolol and clonidine on stress and chemically induced gastric ulcers in rats. Arch. Int. Pharmacodyn., 323, 97-123.
3. Auguste, L., Sterman, H. R., Stein, T. A. et al. (1990). Effect of verapamil on the gastric mucosal level of PGE2 during stress. J. Surg. Res. Jun: 49(1), 34-36.
4. Banerji, S., Habibuddin, M., Pal, S. P. (1992). Antiulcer and gastric secretory activity of N-phthalolyl γ-aminobutyric acid. Eur. J. Pharmacol. 219, 211-215.
5. Baumgartner, H. K., Staradub, O. T., Joehl, J. S. et al. (2004), Cyclooxygenase 1 is required for pH control at the mouse gastric surface, Gut 53. 1751-1757.
6. Burke, A., Smyth, E., Fitzgerald, G. A. (2006). Analgesic-Antipyretic Agents; Pharmacotherapy of gout, in: Goodman and Gilman's The Pharmacolog,cal Basis of Therapeutics, Brunton L. L., Lazo J. S. and Parker K. L. (Eds), eleventh ed. pp. 671-716. Mc Graw Hill, New York,
7. Chandrasekharan, N. V., Dai, H., Ross, K. L. et al. (2002). COX-3, a cyclocenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc. Natl. Acad. Sci USA 99(21), 13926-13931.
8. Corne, S. J., Morrissey, S. M., Wood, R. J. A. (1974). A method for the quantitative estimation of gastric berrier mucus. J. Physiol. Lond., 242, 116-117.
9. Davies, N. M., Sharkey, K. A., Asfaha, S. et al. (1997). Aspirin causes rapid up regulation of cyclo-oxigenase-2 expression in the stomach of rats. Aliment Pharmacol Ther. 11(6), 1101-1108.
10. Gerber, J. G., Nies, A. S., Payne, N. A. (1985). Adenosine receptors ocanine parietal cells modulate gastric acid secretion to histamine. JPET, 233(3), 623-627.
11. Goldman, H., Rosoff, C. B. (1968). Pathogenesis of acute gastric stress ulcers. Am. J. Pathol. 52, 227-244.
12. Goldstein, S. L., Silverstein, F. E., Agrawasl, N. M. et al. (2000). Reduced risk of upper gastrointestinal caomplications with celecoxib, a novel COX-2 inhibitor. Am. J. Gastroenterol. 95(7), 1681-1690.
13. Gürbüz, V., Alican, ., Yegen, B. Ç. et al., (1999). Role of nitric oxide in indomethacin-induced gastric mucosal dysfunction in the rat. Experimental Physiology., 84, 319-332.
14. Hawkey, C. J. (1999). COX-2 inhibitors. Lancet, 353, 307-314.
15. Hubbard, R., Geis, G. S., Yu, S. et al.(1998). Efficacy, tolerability and safety of celecoxib, a specific COX-2 inhibitor, in osteoarthritis. Arthritis. Rheum., 41(Suppl.9), 196.
16. Kitagawa, H., Takada, F., Kohei, H. (1986). A simple method for estimation of gastric mucus and effects antiulcerogenic agents on the decrease in mucus during water-immersion stress in rats. Arzn. Forsch. Drug. Res., 36, 1240-1244.
17. Kobayashi, T., Ohta, Y., Yoshino, J. et al. (2001). Teprenone promotes the healing of acetic acid-induced chronic gastric ulcers in rats by inhibiting neutrophil infiltration and lipids peroxidation in ulcerated gastric tissues. Pharmacol. Res., 43(1), 23-30.
18. Krawisz, J. E., Sharon, P., Stenson, W. F. (1984). Quantitative assay for acute intestinal inflammation besed on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology, 87, 1344-1350.
19. Lanza, F. L., Rack, M. F., Callison, D. A. et al. (1997). A pilot endoscopic study of the gastroduodenal effects of SC-58635, a novel COX-2 selective inhibitor. Gastroenterology, 112A, 194.
20. Lanza, F. L., Rack, M. F., Simon, T. J. et al. (1999). Specific inhibitors of cyclooxygenase-2 with MK-0966 are an associated with less gastroduodenal damage than either aspirin or ibuprofen. Aliment. Pharmacol. Ther., 13, 761-767.
21. Laudonno, O. M., San Miguel, P., Aramberry, L. J. et al. (2003). Mechanism of inhibition of COX-2 and COX-3 in gastrointestinal damage induced by NSAID in rats. Acta Gastroenterol. Latinoam. 33(4), 183-185
22. Lichtenberger, L. M., Wang, Z. M., Romero, J. J. et al. (1995). Non-steroidal antiinflammatory drugs (NSAIDs) associate with zwitler-ionic phosholipids: insight into the mechanism and reversal of NSAID-induced gastric intestinal injury. Nat. Med., 1, 154-158.
23. Luo, L. C., Shin, V. Y., Liu, E. S. L. et al. (2003), Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats, J Pharm Exp Ther 307(2), 692-698.
24. Mukorami, M., Lam, S. K., Inado, M., et al. (1985). Pathophysiology and pathogenesis of acute gastric mucosal lesions after hypothermic restraint stress in rats. Gastroenterology, 88, 660-665.
25. Ogino, K., Hobara, T., Ishiyama, H., et al. (1992). Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate- induced antral gastric ulcers in rats. Eur. J. Pharmacol., 212, 9-13.
26. Ogle, C. W., Cho, C. C., Tong, et al. (1985). The infl uence of verapamil on gastric effects of stress in rats. Eur. J. Pharmacol. 112, 399-404.
27. Penning, T. D., Talley, J. J., Bertenshaw, S. R. et al. (1997). Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(tri-fluoromethyl)-1H- pyarzol-1-yl] benzensulfonamide (SC-58635, celecoxib). J. Med. Chem., 40, 1347-1365.
28. Sawaoka, H, Tsuji, S., Tsujii, M. et al. (1997), Expression of cyclooxygenase-2 gene in gastric epithelium, J Clin Gastroenterol. 25 (Suppl 1), S105-S110.
29. Sayan, H., Gönül, B., Akbulut, K. G., et al. (2001). Effects of epidermal growth factor formulations on liver malonaldehyde and reduced glutathione levels in stress ulcer model. FABAD J. Pharm. Sci., 26, 61-66.
30. Simon, L. S., Lanza, F. L., Lipsky, P. E. et al. (1998). Preliminary study of the safety and efficacy of SC-58635, a novel COX-2 inhibitor. Arthriti. Rheum., 41, 1591-1602.
31. Simon, L. (1999). Role and regulation f cyclo-oxygenase during inflammati?n. Am. J. Med., 106, 37-42.
32. Song, D. U., Ryu, M. H., Chay, K. O. et al. (1998). Effect of rebamipide on the glycosaminoglycan content of ulcerated rat stomach. Fundam. Clin. Pharmacol., 12, 546-552.
33. Song, D. U., Wiever, A., Garham, D. et al. (1999). Antiiflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial. JAMA; November 282 (20), 1921-1928.
34. Suzuki, Y., Hayashi, M., Ito, M. et al. (1976). Antiulcer effects of 4′-(2-carboxyethyl) phenyl trans-4-aminomethyl cyclooxygenase carboxylate hydrochloride (Cetroxate) on various experimental gastric ulcers in rats. Japan J. Pharmacol. 26, 471-480.
35. Suzuki, K., Ota, H., Sasagawa, S. et al. (1983) Assay method for myeloperoxidase in humanpolymorphonuclear leukocytes. Anal. Biochem., 132, 345-353.
36. Takeeda, M., Hayashi, Y., Yamato, M. et al. (2004). Roles of endogenous prostaglandins and cyclooxygenase isozymes in mucosal defense of inflammed rat stomach. J. Physiol. Pharmacol. 55, 193-205.
37. Takezono, Y., Joh, T., Oshima, T. et al. (2004). Role of prostaglandins in maintaining gastric mucus-cell permeability against acid exposure, J. Lab. Clin. Med., 143, 52-58.
38. Tanaka, A., Araki, H., Komoike, Y. et al. (2001). Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J. Physiol. Paris 95, 21-27.
39. Tar?q, M., Agel, A. M. (1999). Gastric antiulcer and cytoprotective effects of dipyridamole in rats. JPET., 253(3), 944-949.
40. Villegas, I., Casa, C. L., de la Lastra, C. A. et al. (2004), Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: Role of prostaglandins and inflammatory response, Life Sci.74, 873-884.
41. Wallace, J. L. (2001). Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Practice and Research Clinical Gastroenterology, 15(5), 691-703.
42. Wallace, J.R., McKnight, W., Renter B. K. et al. (2000). NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology, 119, 705-714.
43. Warner, T. D., Giuliana, F., Vojnovic, I. et al. (1999). Nonsteroidal drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. USA, 96, 7563-7568.
44. Whittle, B. J. R. (1992). Unwanted effects of aspirin and related agents in gastrointestinal tract. In: Vane, J. R., Botting, R. M. (Eds.). Aspirin and other salicylates, pp. 465-509. Chapman and Hall, London.
45. Whittle, B. J. R. (1999). Pharmacological approach to the prevention of non-steroidal antiinflammatory drug-induced gastropathy. Ital. J. Gastroenterol. Hepatol., 31 (Suppl.1), 43-47.